• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)患者全科医疗人群中肺量计测试的有效性。

Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD).

作者信息

Schermer T R, Jacobs J E, Chavannes N H, Hartman J, Folgering H T, Bottema B J, van Weel C

机构信息

Department of General Practice, University Medical Centre Nijmegen, The Netherlands.

出版信息

Thorax. 2003 Oct;58(10):861-6. doi: 10.1136/thorax.58.10.861.

DOI:10.1136/thorax.58.10.861
PMID:14514938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1746497/
Abstract

OBJECTIVE

To investigate the validity of spirometric tests performed in general practice.

METHOD

A repeated within subject comparison of spirometric tests with a "gold standard" (spirometric tests performed in a pulmonary function laboratory) was performed in 388 subjects with chronic obstructive pulmonary disease (COPD) from 61 general practices and four laboratories. General practitioners and practice assistants undertook a spirometry training programme. Within subject differences in forced expiratory volume in 1 second and forced vital capacity (DeltaFEV1 and DeltaFVC) between laboratory and general practice tests were measured (practice minus laboratory value). The proportion of tests with FEV1 reproducibility <5% or <200 ml served as a quality marker.

RESULTS

Mean DeltaFEV1 was 0.069 l (95% CI 0.054 to 0.084) and DeltaFVC 0.081 l (95% CI 0.053 to 0.109) in the first year evaluation, indicating consistently higher values for general practice measurements. Second year results were similar. Laboratory and general practice FEV1 values differed by up to 0.5 l, FVC values by up to 1.0 l. The proportion of non-reproducible tests was 16% for laboratory tests and 18% for general practice tests (p=0.302) in the first year, and 18% for both in the second year evaluation (p=1.000).

CONCLUSIONS

Relevant spirometric indices measured by trained general practice staff were marginally but statistically significantly higher than those measured in pulmonary function laboratories. Because of the limited agreement between laboratory and general practice values, use of these measurements interchangeably should probably be avoided. With sufficient training of practice staff the current practice of performing spirometric tests in the primary care setting seems justifiable.

摘要

目的

探讨在全科医疗中进行肺量计测试的有效性。

方法

对来自61家全科诊所和4个实验室的388例慢性阻塞性肺疾病(COPD)患者进行肺量计测试与“金标准”(在肺功能实验室进行的肺量计测试)的受试者内重复性比较。全科医生和诊所助理参加了肺量计培训项目。测量实验室测试与全科医疗测试之间一秒用力呼气容积和用力肺活量的受试者内差异(诊所测量值减去实验室测量值)。将一秒用力呼气容积重复性<5%或<200ml的测试比例作为质量指标。

结果

第一年评估时,平均一秒用力呼气容积差异为0.069L(95%CI0.054至0.084),用力肺活量差异为0.081L(95%CI0.053至0.109),表明全科医疗测量值始终较高。第二年结果相似。实验室和全科医疗的一秒用力呼气容积值相差可达0.5L,用力肺活量值相差可达1.0L。第一年实验室测试中不可重复测试的比例为16%,全科医疗测试为18%(p=0.302),第二年评估时两者均为18%(p=1.000)。

结论

经培训的全科医疗工作人员测量的相关肺量计指标略高于肺功能实验室测量的指标,但具有统计学意义。由于实验室和全科医疗测量值之间的一致性有限,可能应避免交替使用这些测量值。通过对诊所工作人员进行充分培训,在基层医疗环境中进行肺量计测试的现行做法似乎是合理的。

相似文献

1
Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病(COPD)患者全科医疗人群中肺量计测试的有效性。
Thorax. 2003 Oct;58(10):861-6. doi: 10.1136/thorax.58.10.861.
2
Fixed ratio or lower limit of normal for the FEV /VC ratio: relation to symptoms and extended lung function tests.第一秒用力呼气容积与用力肺活量比值的固定比值或正常下限:与症状及扩展肺功能测试的关系
Clin Physiol Funct Imaging. 2017 May;37(3):263-269. doi: 10.1111/cpf.12294. Epub 2015 Oct 6.
3
Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?高危人群中慢性阻塞性肺疾病的检测:诊断检查应包括支气管扩张剂可逆性测试吗?
Int J Chron Obstruct Pulmon Dis. 2015 Feb 23;10:407-14. doi: 10.2147/COPD.S76047. eCollection 2015.
4
A Simple Measure to Assess Hyperinflation and Air Trapping: 1-Forced Expiratory Volume in Three Second / Forced Vital Capacity.一种评估过度充气和空气陷闭的简易方法:1-用力呼气量/用力肺活量。
Balkan Med J. 2017 Apr 5;34(2):113-118. doi: 10.4274/balkanmedj.2015.0857.
5
Attaining a correct diagnosis of COPD in general practice.在全科医疗中实现慢性阻塞性肺疾病的准确诊断。
Respir Med. 2005 Apr;99(4):493-500. doi: 10.1016/j.rmed.2004.09.015. Epub 2004 Nov 11.
6
Office spirometry in primary care pediatrics: a pilot study.基层儿科医疗中的办公室肺量计检查:一项试点研究。
Pediatrics. 2005 Dec;116(6):e792-7. doi: 10.1542/peds.2005-0487.
7
Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.六秒肺活量在慢性阻塞性肺疾病患者中的预后价值:一项队列研究
PLoS One. 2015 Oct 21;10(10):e0140855. doi: 10.1371/journal.pone.0140855. eCollection 2015.
8
A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.一项基于医院的关于慢性阻塞性肺疾病及其他疾病患者肺功能测试和运动耐量的研究。
J Indian Med Assoc. 2007 Oct;105(10):565-6, 568, 570 passim.
9
The objective evaluation of obstructive pulmonary diseases with spirometry.通过肺量计对阻塞性肺疾病进行客观评估。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 25;11:2009-15. doi: 10.2147/COPD.S113774. eCollection 2016.
10
Primary care spirometry: test quality and the feasibility and usefulness of specialist reporting.基层医疗中的肺功能测定:检测质量以及专科报告的可行性与实用性。
Br J Gen Pract. 2007 Sep;57(542):701-5.

引用本文的文献

1
Reply: Spirometry remains the GOLD standard test for COPD diagnosis.回复:肺量测定法仍然是慢性阻塞性肺疾病(COPD)诊断的金标准测试。
Eur Respir J. 2025 Jun 5;65(6). doi: 10.1183/13993003.00794-2025. Print 2025 Jun.
2
Pulmonary function testing dataset of pressure and flow, dynamic circumference, heart rate, and aeration monitoring.压力与流量、动态周长、心率及通气监测的肺功能测试数据集
Data Brief. 2024 Apr 4;54:110386. doi: 10.1016/j.dib.2024.110386. eCollection 2024 Jun.
3
Single breath count test and its applications in clinical practice: a systematic review.单次呼吸计数测试及其在临床实践中的应用:一项系统评价
Ann Med Surg (Lond). 2024 Feb 28;86(4):2130-2136. doi: 10.1097/MS9.0000000000001853. eCollection 2024 Apr.
4
Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis.用于为囊性纤维化患者提供和监测运动方案的数字技术。
Cochrane Database Syst Rev. 2023 Jun 9;6(6):CD014605. doi: 10.1002/14651858.CD014605.pub2.
5
Diaphragmatic ultrasound can help evaluate pulmonary dysfunction in patients with stroke.膈肌超声有助于评估中风患者的肺功能障碍。
Front Neurol. 2023 Apr 18;14:1061003. doi: 10.3389/fneur.2023.1061003. eCollection 2023.
6
Respiratory questionnaire-based analysis of awareness of COPD in a large multicenter rural population-based study in India.在印度一项基于农村人群的大型多中心研究中,基于呼吸问卷对慢性阻塞性肺疾病(COPD)知晓情况的分析。
Chronic Dis Transl Med. 2022 Sep 17;8(4):322-330. doi: 10.1002/cdt3.47. eCollection 2022 Dec.
7
Diagnostic differentiation between asthma and COPD in primary care using lung function testing.在初级保健中使用肺功能测试对哮喘和 COPD 进行诊断鉴别。
NPJ Prim Care Respir Med. 2022 Sep 5;32(1):32. doi: 10.1038/s41533-022-00298-4.
8
Effects of Muscle Energy Technique and Joint Manipulation on Pulmonary Functions, Mobility, Disease Exacerbations, and Health-Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients: A Quasiexperimental Study.肌肉能量技术和关节手法对慢性阻塞性肺疾病患者肺功能、活动能力、疾病恶化和健康相关生活质量的影响:一项准实验研究。
Biomed Res Int. 2022 Jul 30;2022:5528724. doi: 10.1155/2022/5528724. eCollection 2022.
9
Prediction of Pulmonary Function Parameters Based on a Combination Algorithm.基于组合算法的肺功能参数预测
Bioengineering (Basel). 2022 Mar 25;9(4):136. doi: 10.3390/bioengineering9040136.
10
Validity of a portable spirometer in the communities of China.一种便携式肺活量计在中国社区的有效性。
BMC Pulm Med. 2022 Mar 5;22(1):80. doi: 10.1186/s12890-022-01872-9.

本文引用的文献

1
Evaluation of diagnostic procedures.诊断程序的评估。
BMJ. 2002 Feb 23;324(7335):477-80. doi: 10.1136/bmj.324.7335.477.
2
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.慢性阻塞性肺疾病诊断、管理和预防全球策略。美国国立心肺血液研究所/世界卫生组织慢性阻塞性肺疾病全球倡议(GOLD)研讨会总结。
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76. doi: 10.1164/ajrccm.163.5.2101039.
3
Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.成人肺部健康评估的办公室肺量计检查:国家肺部健康教育计划的共识声明。
Chest. 2000 Apr;117(4):1146-61. doi: 10.1378/chest.117.4.1146.
4
Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice.在全科医疗中,通过肺活量测定法和可逆性测试来识别哮喘登记册上慢性阻塞性肺疾病患者的可行性。
Respir Med. 1999 Dec;93(12):903-8. doi: 10.1016/s0954-6111(99)90057-4.
5
Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops.基层医疗实践中的肺功能测定:质量保证的重要性及肺功能测定研讨会的影响
Chest. 1999 Aug;116(2):416-23. doi: 10.1378/chest.116.2.416.
6
Diurnal variation in lung function in subgroups from two Dutch populations: consequences for longitudinal analysis.来自两个荷兰人群亚组的肺功能昼夜变化:对纵向分析的影响。
Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1163-71. doi: 10.1164/ajrccm.159.4.9703106.
7
A re-audit of pulmonary function laboratories in the West Midlands.西米德兰兹郡肺功能实验室的再次审核
Respir Med. 1998 Sep;92(9):1155-62. doi: 10.1016/s0954-6111(98)90411-5.
8
Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program.普通人群中慢性阻塞性肺疾病和哮喘的主动检测。DIMCA项目的结果及经济影响。
Am J Respir Crit Care Med. 1998 Dec;158(6):1730-8. doi: 10.1164/ajrccm.158.6.9709003.
9
Long-term performance of a hand held spirometer.手持式肺活量计的长期性能
Thorax. 1996 Oct;51(10):973-6. doi: 10.1136/thx.51.10.973.
10
Patient-administered sequential spirometry in healthy volunteers and patients with alpha 1-antitrypsin deficiency.健康志愿者和α1-抗胰蛋白酶缺乏症患者的患者自主连续肺活量测定法
Respir Med. 1996 Mar;90(3):131-8. doi: 10.1016/s0954-6111(96)90154-7.